Related Experiment Video
Updated: Feb 17, 2026

07:57
Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation
Published on: August 21, 2019
9.2K
Crowdsourcing Disease Biomarker Discovery Research: The IP4IC Study
Michael B Chancellor1, Sarah N Bartolone2, Andrew Veerecke2
1Oakland University William Beaumont School of Medicine, Rochester Hills, Michigan.
The Journal of Urology
|December 12, 2017
Summary
A novel crowdsourcing method developed a Bladder Permeability Defect Risk Score (BP-RS) using urinary cytokines. This new biomarker accurately predicts interstitial cystitis/bladder pain syndrome with Hunner lesions.
Area of Science:
- Biomarkers
- Urology
- Machine Learning
Background:
- Biomarker discovery is challenged by sample accessibility and disease heterogeneity.
- Interstitial cystitis/bladder pain syndrome (IC/BPS) diagnosis can be difficult, especially identifying Hunner lesions.
Purpose of the Study:
- To develop a novel, cost-efficient crowdsourcing method for biomarker discovery.
- To create a Bladder Permeability Defect Risk Score (BP-RS) using noninvasive urinary cytokines to identify IC/BPS patients with Hunner lesions.
Main Methods:
- A national crowdsourcing study collected urine samples from IC/BPS patients and controls.
- Demographic and symptom data were gathered via online questionnaires.
- A machine learning algorithm analyzed 3 urinary cytokines to develop the BP-RS.
Main Results:
- The IP4IC study collected 448 urine samples from 153 IC/BPS patients (54 with Hunner lesions) and 295 controls.
- The developed BP-RS predicted IC/BPS with Hunner lesions (indicating bladder permeability defect) with 89% validity.
- Crowdsourcing enabled collection of a large, diverse sample set from 46 states.
Conclusions:
- BP-RS is the first validated urine biomarker assay for IC/BPS, specifically identifying Hunner lesions.
- Crowdsourcing offers a viable method for large-scale biomarker assay development.
- This approach facilitates the study of disease heterogeneity using accessible samples.
Related Concept Videos
EPS and iPS Cells in Disease Research
3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
